Cysteamine (Cystagon(R)) adherence in patients with cystinosis in Spain: successful in children and a challenge in adolescents and adults

Quality of Life is Improved and Kidney Function Preserved in Patients with Nephropathic Cystinosis Treated for 2 Years with Delayed-Release Cysteamine Bitartrate

(2014) Craig B. Langman et al.   JOURNAL OF PEDIATRICS

Nephropathic cystinosis: an international consensus document

(2014) F. Emma et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Adherence to transition guidelines in European paediatric nephrology units

(2014) Thomas A. Forbes et al.   PEDIATRIC NEPHROLOGY

A Randomized Controlled Crossover Trial with Delayed-Release Cysteamine Bitartrate in Nephropathic Cystinosis: Effectiveness on White Blood Cell Cystine Levels and Comparison of Safety

(2012) C. B. Langman et al.   Clinical Journal of the American Society of Nephrology

Cystinosis: the evolution of a treatable disease

(2012) Galina Nesterova et al.   PEDIATRIC NEPHROLOGY

Improvement in the Renal Prognosis in Nephropathic Cystinosis

(2011) K. J. Van Stralen et al.   Clinical Journal of the American Society of Nephrology

Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA)

(2011) Alan R. Watson et al.   KIDNEY INTERNATIONAL

Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults

(2011) Albane Brodin-Sartorius et al.   KIDNEY INTERNATIONAL

Cystinosis: practical tools for diagnosis and treatment

(2010) Martijn J. Wilmer et al.   PEDIATRIC NEPHROLOGY

Late-Onset Nephropathic Cystinosis: Clinical Presentation, Outcome, and Genotyping

(2008) A. Servais et al.   Clinical Journal of the American Society of Nephrology